LONDON, September 23 /PRNewswire/ -- Following Prime Minister Gordon Brown's speech today at the Labour party conference, the MS Society welcomes news of a commitment to end prescription charges for people with long-term conditions.

Speaking at the conference in Manchester, Mr Gordon Brown said: "....so our plan is next year to abolish all prescription charges for everyone with cancer. And this is not the limit of our commitment to a fair NHS. In the long term, the NHS generates cash savings in its budget we will plough savings back into abolishing charges for all patients with long-term conditions."

LONDON, September 23 /PRNewswire/ --

The Georgian National Communications Commission (GNCC) announced a fine of more than US$360,000 against the Russian telecom company Megafon for operating without a license within Georgian territory. Officials claim that despite previous administrative sanctions against Megafon, the company persists in illegal use of the Georgian radiofrequency spectrum to provide mobile telecommunications services.

LONDON, September 23 /PRNewswire/ -- Commenting on the promise to abolish prescription charges for cancer patients, the Chair of the English Pharmacy Board of the Royal Pharmaceutical Society of Great Britain, Beth Taylor said:

"This is good news for those affected by cancer. It is unfair for cancer patients to have to deal with the added financial burden of prescription charges and we see at first hand the anguish that this can cause.

LONDON, September 23 /PRNewswire/ --

At the 2008 SMM maritime technology exhibition this month, Northrop Grumman Corporation's (NYSE: NOC) Sperry Marine business unit will unveil the newest enhancement to its VisionMaster FT(TM) lineup of marine navigation systems -- a widescreen high-resolution display with 25 percent more viewing area.

A photo accompanying this release is available at: http://media.primezone.com/noc/

BAGNOLS-SUR-CÈZE, France, September 23 /PRNewswire/ --

- Company's Expertise in Chromogranin A Tumor Detection Marker Technology Now Applied to Universal Technique

CISBIO Bioassays, a member of IBA group and a developer and marketer of diagnostic assays for the quantification of tumor markers, announced today the launch of its chromogranin A ELISA diagnostic tool, Chromoa. This ELISA kit complements CISBIO's existing chromogranin A RIACT kit and can be used by all laboratories for the detection and monitoring of neuroendocrine tumors.

LONDON, September 23 /PRNewswire/ --

- Proven to Significantly Outperform Existing GPS Antennas

- Patented Technology Enabling Hands-Free Pedestrian Navigation

- Proven to Reduce Drain on Battery Life by More Than 10 Percent

- Small Enough to Fit in the Slimmest and Most Compact Handset Models

- Samples Available on https://samples.sarantel.com

LONDON, September 23 /PRNewswire/ --

COPENHAGEN, September 23 /PRNewswire/ --

- Summary: Genmab has Completed Recruitment of Patients in the Phase III Study of Ofatumumab in Rituximab Refractory Follicular NHL.

AMSTERDAM - Metering, Billing/CRM Europe 2008, September 23 /PRNewswire/ -- Alcatel-Lucent (Euronext Paris and NYSE: ALU) and Deutsche Telekom today announced that they launch a web-based Smart Metering user interface for the E-Metering field trial, which is running in the German city of Friedrichshafen.

BOSTON, September 23 /PRNewswire/ --

LONDON, September 23 /PRNewswire/ -- FindAdBlue.com (http://www.findadblue.com/) is pleased to announce that it will be exhibiting at the 62nd IAA Commercial Vehicles in Hannover from 25 September to 2 October 2008. The FindAdBlue.com stand will provide visitors to the show with information about diesel SCR technology and AdBlue, maps showing AdBlue availability in Europe, and advice on the ways to buy and use AdBlue. The FindAdBlue.com stand will be located in Hall 18, at A25. The sponsors of FindAdBlue.com at the 62nd IAA Commercial Vehicles are Mercedes-Benz, Renault Truck Company, Scania and Yara Air1.